|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ARHGDIA-SQSTM1 (FusionGDB2 ID:HG396TG8878) |
Fusion Gene Summary for ARHGDIA-SQSTM1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ARHGDIA-SQSTM1 | Fusion gene ID: hg396tg8878 | Hgene | Tgene | Gene symbol | ARHGDIA | SQSTM1 | Gene ID | 396 | 8878 |
Gene name | Rho GDP dissociation inhibitor alpha | sequestosome 1 | |
Synonyms | GDIA1|HEL-S-47e|NPHS8|RHOGDI|RHOGDI-1 | A170|DMRV|FTDALS3|NADGP|OSIL|PDB3|ZIP3|p60|p62|p62B | |
Cytomap | ('ARHGDIA')('SQSTM1') 17q25.3 | 5q35.3 | |
Type of gene | protein-coding | protein-coding | |
Description | rho GDP-dissociation inhibitor 1GDP-dissociation inhibitor, aplysia RAS-related 1Rho GDP dissociation inhibitor (GDI) alphaepididymis secretory sperm binding protein Li 47e | sequestosome-1EBI3-associated protein of 60 kDaEBI3-associated protein p60EBIAPautophagy receptor p62oxidative stress induced likephosphotyrosine independent ligand for the Lck SH2 domain p62phosphotyrosine-independent ligand for the Lck SH2 domain | |
Modification date | 20200327 | 20200327 | |
UniProtAcc | . | Q13501 | |
Ensembl transtripts involved in fusion gene | ENST00000269321, ENST00000582520, ENST00000400721, ENST00000541078, ENST00000580685, ENST00000581876, ENST00000584461, | ||
Fusion gene scores | * DoF score | 7 X 4 X 4=112 | 33 X 21 X 17=11781 |
# samples | 7 | 38 | |
** MAII score | log2(7/112*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(38/11781*10)=-4.95431877505661 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ARHGDIA [Title/Abstract] AND SQSTM1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ARHGDIA(79825598)-SQSTM1(179250858), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ARHGDIA-SQSTM1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARHGDIA-SQSTM1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARHGDIA-SQSTM1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ARHGDIA-SQSTM1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SQSTM1 | GO:0006914 | autophagy | 20452972 |
Tgene | SQSTM1 | GO:0007032 | endosome organization | 27368102 |
Tgene | SQSTM1 | GO:0031397 | negative regulation of protein ubiquitination | 20452972 |
Tgene | SQSTM1 | GO:0061635 | regulation of protein complex stability | 25127057 |
Tgene | SQSTM1 | GO:1905719 | protein localization to perinuclear region of cytoplasm | 27368102 |
Fusion gene breakpoints across ARHGDIA (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SQSTM1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | HNSC | TCGA-CR-7398-01A | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
ChimerDB4 | SKCM | TCGA-EB-A1NK-01A | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
Top |
Fusion Gene ORF analysis for ARHGDIA-SQSTM1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000269321 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000269321 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000269321 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000269321 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000269321 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000582520 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000582520 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000582520 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000582520 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
5CDS-intron | ENST00000582520 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
In-frame | ENST00000269321 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
In-frame | ENST00000582520 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-3CDS | ENST00000400721 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-3CDS | ENST00000541078 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-3CDS | ENST00000580685 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-3CDS | ENST00000581876 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-3CDS | ENST00000584461 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000400721 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000400721 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000400721 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000400721 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000400721 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000541078 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000541078 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000541078 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000541078 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000541078 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000580685 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000580685 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000580685 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000580685 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000580685 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000581876 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000581876 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000581876 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000581876 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000581876 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000584461 | ENST00000360718 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000584461 | ENST00000389805 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000584461 | ENST00000402874 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000584461 | ENST00000506690 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
intron-intron | ENST00000584461 | ENST00000510187 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000582520 | ARHGDIA | chr17 | 79825598 | - | ENST00000376929 | SQSTM1 | chr5 | 179250858 | + | 2749 | 245 | 304 | 1266 | 320 |
ENST00000269321 | ARHGDIA | chr17 | 79825598 | - | ENST00000376929 | SQSTM1 | chr5 | 179250858 | + | 4410 | 1906 | 1965 | 2927 | 320 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000582520 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + | 0.022531757 | 0.97746825 |
ENST00000269321 | ENST00000376929 | ARHGDIA | chr17 | 79825598 | - | SQSTM1 | chr5 | 179250858 | + | 0.037863262 | 0.9621368 |
Top |
Fusion Genomic Features for ARHGDIA-SQSTM1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ARHGDIA | chr17 | 79825596 | - | SQSTM1 | chr5 | 179250857 | + | 1.69E-06 | 0.99999833 |
ARHGDIA | chr17 | 79825596 | - | SQSTM1 | chr5 | 179250857 | + | 1.69E-06 | 0.99999833 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ARHGDIA-SQSTM1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:79825598/chr5:179250858) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | SQSTM1 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Autophagy receptor required for selective macroautophagy (aggrephagy). Functions as a bridge between polyubiquitinated cargo and autophagosomes. Interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family (PubMed:16286508, PubMed:20168092, PubMed:24128730, PubMed:28404643, PubMed:22622177). Along with WDFY3, involved in the formation and autophagic degradation of cytoplasmic ubiquitin-containing inclusions (p62 bodies, ALIS/aggresome-like induced structures). Along with WDFY3, required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed:24128730, PubMed:20168092). May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1. May play a role in titin/TTN downstream signaling in muscle cells. May regulate signaling cascades through ubiquitination. Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). May be involved in cell differentiation, apoptosis, immune response and regulation of K(+) channels. Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed:20452972, PubMed:28380357, PubMed:33393215). {ECO:0000250|UniProtKB:O08623, ECO:0000250|UniProtKB:Q64337, ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10747026, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:12471037, ECO:0000269|PubMed:15340068, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:15911346, ECO:0000269|PubMed:15953362, ECO:0000269|PubMed:16079148, ECO:0000269|PubMed:16286508, ECO:0000269|PubMed:19931284, ECO:0000269|PubMed:20168092, ECO:0000269|PubMed:20452972, ECO:0000269|PubMed:22622177, ECO:0000269|PubMed:24128730, ECO:0000269|PubMed:27368102, ECO:0000269|PubMed:28380357, ECO:0000269|PubMed:28404643, ECO:0000269|PubMed:29496741, ECO:0000269|PubMed:33393215}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 272_294 | 16 | 357.0 | Compositional bias | Note=Ser-rich | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 272_294 | 16 | 357.0 | Compositional bias | Note=Ser-rich | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 272_294 | 100 | 441.0 | Compositional bias | Note=Ser-rich | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 272_294 | 16 | 357.0 | Compositional bias | Note=Ser-rich | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 389_434 | 16 | 357.0 | Domain | UBA | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 389_434 | 16 | 357.0 | Domain | UBA | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 389_434 | 100 | 441.0 | Domain | UBA | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 389_434 | 16 | 357.0 | Domain | UBA | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 228_233 | 16 | 357.0 | Motif | Note=TRAF6-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 336_341 | 16 | 357.0 | Motif | Note=LIR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 228_233 | 16 | 357.0 | Motif | Note=TRAF6-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 336_341 | 16 | 357.0 | Motif | Note=LIR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 228_233 | 100 | 441.0 | Motif | Note=TRAF6-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 336_341 | 100 | 441.0 | Motif | Note=LIR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 228_233 | 16 | 357.0 | Motif | Note=TRAF6-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 336_341 | 16 | 357.0 | Motif | Note=LIR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 170_220 | 16 | 357.0 | Region | Note=LIM protein-binding (LB) | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 321_342 | 16 | 357.0 | Region | MAP1LC3B-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 170_220 | 16 | 357.0 | Region | Note=LIM protein-binding (LB) | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 321_342 | 16 | 357.0 | Region | MAP1LC3B-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 170_220 | 100 | 441.0 | Region | Note=LIM protein-binding (LB) | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 321_342 | 100 | 441.0 | Region | MAP1LC3B-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 170_220 | 16 | 357.0 | Region | Note=LIM protein-binding (LB) | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 321_342 | 16 | 357.0 | Region | MAP1LC3B-binding | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 122_167 | 16 | 357.0 | Zinc finger | ZZ-type | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 122_167 | 16 | 357.0 | Zinc finger | ZZ-type | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 122_167 | 100 | 441.0 | Zinc finger | ZZ-type | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 122_167 | 16 | 357.0 | Zinc finger | ZZ-type |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 3_102 | 16 | 357.0 | Domain | PB1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 3_102 | 16 | 357.0 | Domain | PB1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 3_102 | 100 | 441.0 | Domain | PB1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 3_102 | 16 | 357.0 | Domain | PB1 |
Top |
Fusion Gene Sequence for ARHGDIA-SQSTM1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>6165_6165_1_ARHGDIA-SQSTM1_ARHGDIA_chr17_79825598_ENST00000269321_SQSTM1_chr5_179250858_ENST00000376929_length(transcript)=4410nt_BP=1906nt GAGCGGAAGTCTCGTGACCCCGGAAGTGACAGGCAGGGCGGGCGGGGCGGCCGACGACGTTCGTCATTTAGTGCGGGAGGGATCCTGAAC CGCGCGGCCGAACCCTCCGGTGTCCCGACCCAGGCTAAGCTTGAGCATGGCTGAGCAGGAGCCCACAGCCGAGCAGCTGGCCCAGATTGC AGCGGAGAACGAGGAGGATGAGCACTCGGTCAACTACAAGCCCCCGGCCCAGAAGAGCATCCAGGAGATCCAGGAGCTGGACAAGGACGA CGAGAGCCTGCGAAAGTACAAGGAGGCCCTGCTGGGCCGCGTGGCCGTTTCCGCAGACCCCAACGTCCCCAACGTCGTGGTGACTGGCCT GACCCTGGTGTGCAGCTCGGCCCCGGGCCCCCTGGAGCTGGACCTGACGGGCGACCTGGAGAGCTTCAAGAAGCAGTCGTTTGTGCTGAA GGAGGGTGTGGAGTACCGGATAAAAATCTCTTTCCGGGTTAACCGAGAGATAGTGTCCGGCATGAAGTACATCCAGCATACGTACAGGAA AGGCGTCAAGATTGACAAGACTGACTACATGGTAGGCAGCTATGGGCCCCGGGCCGAGGAGTACGAGTTCCTGACCCCCGTGGAGGAGGC ACCCAAGGGTATGCTGGCCCGGGGCAGCTACAGCATCAAGTCCCGCTTCACAGACGACGACAAGACCGACCACCTGTCCTGGGAGTGGAA TCTCACCATCAAGAAGGACTGGAAGGACTGAGCCCAGCCAGAGGCGGGCAGGGCAGACTGACGGACGGACGACGGACAGGCGGATGTGTC CCCCCCAGCCCCTCCCCTCCCCATACCAAAGTGCTGACAGGCCCTCCGTGCCCCTCCCACCCTGGTCCGCCTCCCTGGCCTGGCTCAACC GAGTGCCTCCGACCCCCCTCCTCAGCCCTCCCCCACCCACAGGCCCAGCCTCCTCGGTCTCCTGTCTCGTTGCTGCTTCTGCCTGTGCTG TGGGGGAGAGAGGCCGCAGCCAGGCCTCTGCTGCCCTTTCTGTGCCCCCCAGGTTCTATCTCCCCGTCACACCCGAGGCCTGGCTTCAGG AGGGAGCGGAGCAGCCATTCTCCAGGCCCCGTGGTTGCCCCTGGACGTGTGCGTCTGCTGCTCCGGGGTGGAGCTGGGGTGTGGGATGCA CGGCCTCGTGGGGGCCGGGCCGTCCTCCAGCCCCGCTGCTCCCTGGCCAGCCCCCTTGTCGCTGTCGGTCCCGTCTAACCATGATGCCTT AACATGTGGAGTGTACCGTGGGGCCTCACTAGCCTCTAACTCCCTGTGTCTGCATGAGCATGTGGCCTCCCCGTCCCTTCCCCGGTGGCG AACCCAGTGACCCAGGGACACGTGGGGTGTGCTGCTGCTGCTCCCCAGCCCACCAGTGCCTGGCCAGCCTGCCCCCTTCCCTGGACAGGG CTGTGGAGATGGCTCCGGCGGCTTGGGGAAAGCCAAATTGCCAAAACTCAAGTCACCTCAGTACCATCCAGGAGGCTGGGTATTGTCCTG CCTCTGCCTTTTCTGTCTCAGCGGGCAGTGCCCAGAGCCCACACCCCCCCAAGAGCCCTCGATGGACAGCCTCACTCACCCCACCTGGGC CCAGCCAGGAGCCCCGCCTGGCCATCAGTATTTATTGCCTCCGTCCGTGCCGTCCCTGGGCCACTGGCCTGGCGCCTGTTCCCCCAGGCT CTCAGTGCCACCACCCCCGGCAGGCCTTCCCTGACCCAGCCAGGAACAAACAAGGGACCAAGTGCACACATTGCTGAGAGCCGTCTCCTG TGCCTCCCCCGCCCCATCCCCGGTCTTCGTGTTGTGTCTGCCAGGCTCAGGCAGAGGCGCCTGTCCCTGCTTCTTTTCTGACCGGGAAAT AAATGCCCCTGAAGGAAGAAAAAAGAGTGCCGGCGGGACCACCGCCCACCGTGTGCTCAGGAGGCGCCCCGCAACATGGTGCACCCCAAT GTGATCTGCGATGGCTGCAATGGGCCTGTGGTAGGAACCCGCTACAAGTGCAGCGTCTGCCCAGACTACGACTTGTGTAGCGTCTGCGAG GGAAAGGGCTTGCACCGGGGGCACACCAAGCTCGCATTCCCCAGCCCCTTCGGGCACCTGTCTGAGGGCTTCTCGCACAGCCGCTGGCTC CGGAAGGTGAAACACGGACACTTCGGGTGGCCAGGATGGGAAATGGGTCCACCAGGAAACTGGAGCCCACGTCCTCCTCGTGCAGGGGAG GCCCGCCCTGGCCCCACGGCAGAATCAGCTTCTGGTCCATCGGAGGATCCGAGTGTGAATTTCCTGAAGAACGTTGGGGAGAGTGTGGCA GCTGCCCTTAGCCCTCTGGGCATTGAAGTTGATATCGATGTGGAGCACGGAGGGAAAAGAAGCCGCCTGACCCCCGTCTCTCCAGAGAGT TCCAGCACAGAGGAGAAGAGCAGCTCACAGCCAAGCAGCTGCTGCTCTGACCCCAGCAAGCCGGGTGGGAATGTTGAGGGCGCCACGCAG TCTCTGGCGGAGCAGATGAGGAAGATCGCCTTGGAGTCCGAGGGGCGCCCTGAGGAACAGATGGAGTCGGATAACTGTTCAGGAGGAGAT GATGACTGGACCCATCTGTCTTCAAAAGAAGTGGACCCGTCTACAGGTGAACTCCAGTCCCTACAGATGCCAGAATCCGAAGGGCCAAGC TCTCTGGACCCCTCCCAGGAGGGACCCACAGGGCTGAAGGAAGCTGCCTTGTACCCACATCTCCCGCCAGAGGCTGACCCGCGGCTGATT GAGTCCCTCTCCCAGATGCTGTCCATGGGCTTCTCTGATGAAGGCGGCTGGCTCACCAGGCTCCTGCAGACCAAGAACTATGACATCGGA GCGGCTCTGGACACCATCCAGTATTCAAAGCATCCCCCGCCGTTGTGACCACTTTTGCCCACCTCTTCTGCGTGCCCCTCTTCTGTCTCA TAGTTGTGTTAAGCTTGCGTAGAATTGCAGGTCTCTGTACGGGCCAGTTTCTCTGCCTTCTTCCAGGATCAGGGGTTAGGGTGCAAGAAG CCATTTAGGGCAGCAAAACAAGTGACATGAAGGGAGGGTCCCTGTGTGTGTGTGTGCTGATGTTTCCTGGGTGCCCTGGCTCCTTGCAGC AGGGCTGGGCCTGCGAGACCCAAGGCTCACTGCAGCGCGCTCCTGACCCCTCCCTGCAGGGGCTACGTTAGCAGCCCAGCACATAGCTTG CCTAATGGCTTTCACTTTCTCTTTTGTTTTAAATGACTCATAGGTCCCTGACATTTAGTTGATTATTTTCTGCTACAGACCTGGTACACT CTGATTTTAGATAAAGTAAGCCTAGGTGTTGTCAGCAGGCAGGCTGGGGAGGCCAGTGTTGTGGGCTTCCTGCTGGGACTGAGAAGGCTC ACGAAGGGCATCCGCAATGTTGGTTTCACTGAGAGCTGCCTCCTGGTCTCTTCACCACTGTAGTTCTCTCATTTCCAAACCATCAGCTGC TTTTAAAATAAGATCTCTTTGTAGCCATCCTGTTAAATTTGTAAACAATCTAATTAAATGGCATCAGCACTTTAACCAATGACGTTTGCA TAGAGAGAAATGATTGACAGTAAGTTTATTGTTAATGGTTCTTACAGAGTATCTTTAAAAGTGCCTTAGGGGAACCCTGTCCCTCCTAAC AAGTGTATCTCGATTAATAACCTGCCAGTCCCAGATCACACATCATCATCGAAGTCTTCCCCAGTTATAAAGAGGTCACATAGTCGTGTG GGTCGAGGATTCTGTGCCTCCAGGACCAGGGGCCCACCCTCTGCCCAGGGAGTCCTTGCGTCCCATGAGGTCTTCCCGCAAGGCCTCTCA GACCCAGATGTGACGGGGTGTGTGGCCCGAGGAAGCTGGACAGCGGCAGTGGGCCTGCTGAGGCCTTCTCTTGAGGCCTGTGCTCTGGGG GTCCCTTGCTTAGCCTGTGCTGGACCAGCTGGCCTGGGGTCCCTCTGAAGAGACCTTGGCTGCTCACTGTCCACATGTGAACTTTTTCTA GGTGGCAGGACAAATTGCGCCCATTTAGAGGATGTGGCTGTAACCTGCTGGATGGGACTCCATAGCTCCTTCCCAGGACCCCTCAGCTCC CCGGCACTGCAGTCTGCAGAGTTCTCCTGGAGGCAGGGGCTGCTGCCTTGTTTCACCTTCCATGTCAGGCCAGCCTGTCCCTGAAAGAGA AGATGGCCATGCCCTCCATGTGTAAGAACAATGCCAGGGCCCAGGAGGACCGCCTGCCCTGCCTGGGCCTTGGCTGGGCCTCTGGTTCTG ACACTTTCTGCTGGAAGCTGTCAGGCTGGGACAGGCTTTGATTTTGAGGGTTAGCAAGACAAAGCAAATAAATGCCTTCCACCTCACCGC >6165_6165_1_ARHGDIA-SQSTM1_ARHGDIA_chr17_79825598_ENST00000269321_SQSTM1_chr5_179250858_ENST00000376929_length(amino acids)=320AA_BP= MVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRP PRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNV EGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEA -------------------------------------------------------------- >6165_6165_2_ARHGDIA-SQSTM1_ARHGDIA_chr17_79825598_ENST00000582520_SQSTM1_chr5_179250858_ENST00000376929_length(transcript)=2749nt_BP=245nt AGAGAGGCCGCAGCCAGGCCTCTGCTGCCCTTTCTGTGCCCCCCAGGCTCTCAGTGCCACCACCCCCGGCAGGCCTTCCCTGACCCAGCC AGGAACAAACAAGGGACCAAGTGCACACATTGCTGAGAGCCGTCTCCTGTGCCTCCCCCGCCCCATCCCCGGTCTTCGTGTTGTGTCTGC CAGGCTCAGGCAGAGGCGCCTGTCCCTGCTTCTTTTCTGACCGGGAAATAAATGCCCCTGAAGGAAGAAAAAAGAGTGCCGGCGGGACCA CCGCCCACCGTGTGCTCAGGAGGCGCCCCGCAACATGGTGCACCCCAATGTGATCTGCGATGGCTGCAATGGGCCTGTGGTAGGAACCCG CTACAAGTGCAGCGTCTGCCCAGACTACGACTTGTGTAGCGTCTGCGAGGGAAAGGGCTTGCACCGGGGGCACACCAAGCTCGCATTCCC CAGCCCCTTCGGGCACCTGTCTGAGGGCTTCTCGCACAGCCGCTGGCTCCGGAAGGTGAAACACGGACACTTCGGGTGGCCAGGATGGGA AATGGGTCCACCAGGAAACTGGAGCCCACGTCCTCCTCGTGCAGGGGAGGCCCGCCCTGGCCCCACGGCAGAATCAGCTTCTGGTCCATC GGAGGATCCGAGTGTGAATTTCCTGAAGAACGTTGGGGAGAGTGTGGCAGCTGCCCTTAGCCCTCTGGGCATTGAAGTTGATATCGATGT GGAGCACGGAGGGAAAAGAAGCCGCCTGACCCCCGTCTCTCCAGAGAGTTCCAGCACAGAGGAGAAGAGCAGCTCACAGCCAAGCAGCTG CTGCTCTGACCCCAGCAAGCCGGGTGGGAATGTTGAGGGCGCCACGCAGTCTCTGGCGGAGCAGATGAGGAAGATCGCCTTGGAGTCCGA GGGGCGCCCTGAGGAACAGATGGAGTCGGATAACTGTTCAGGAGGAGATGATGACTGGACCCATCTGTCTTCAAAAGAAGTGGACCCGTC TACAGGTGAACTCCAGTCCCTACAGATGCCAGAATCCGAAGGGCCAAGCTCTCTGGACCCCTCCCAGGAGGGACCCACAGGGCTGAAGGA AGCTGCCTTGTACCCACATCTCCCGCCAGAGGCTGACCCGCGGCTGATTGAGTCCCTCTCCCAGATGCTGTCCATGGGCTTCTCTGATGA AGGCGGCTGGCTCACCAGGCTCCTGCAGACCAAGAACTATGACATCGGAGCGGCTCTGGACACCATCCAGTATTCAAAGCATCCCCCGCC GTTGTGACCACTTTTGCCCACCTCTTCTGCGTGCCCCTCTTCTGTCTCATAGTTGTGTTAAGCTTGCGTAGAATTGCAGGTCTCTGTACG GGCCAGTTTCTCTGCCTTCTTCCAGGATCAGGGGTTAGGGTGCAAGAAGCCATTTAGGGCAGCAAAACAAGTGACATGAAGGGAGGGTCC CTGTGTGTGTGTGTGCTGATGTTTCCTGGGTGCCCTGGCTCCTTGCAGCAGGGCTGGGCCTGCGAGACCCAAGGCTCACTGCAGCGCGCT CCTGACCCCTCCCTGCAGGGGCTACGTTAGCAGCCCAGCACATAGCTTGCCTAATGGCTTTCACTTTCTCTTTTGTTTTAAATGACTCAT AGGTCCCTGACATTTAGTTGATTATTTTCTGCTACAGACCTGGTACACTCTGATTTTAGATAAAGTAAGCCTAGGTGTTGTCAGCAGGCA GGCTGGGGAGGCCAGTGTTGTGGGCTTCCTGCTGGGACTGAGAAGGCTCACGAAGGGCATCCGCAATGTTGGTTTCACTGAGAGCTGCCT CCTGGTCTCTTCACCACTGTAGTTCTCTCATTTCCAAACCATCAGCTGCTTTTAAAATAAGATCTCTTTGTAGCCATCCTGTTAAATTTG TAAACAATCTAATTAAATGGCATCAGCACTTTAACCAATGACGTTTGCATAGAGAGAAATGATTGACAGTAAGTTTATTGTTAATGGTTC TTACAGAGTATCTTTAAAAGTGCCTTAGGGGAACCCTGTCCCTCCTAACAAGTGTATCTCGATTAATAACCTGCCAGTCCCAGATCACAC ATCATCATCGAAGTCTTCCCCAGTTATAAAGAGGTCACATAGTCGTGTGGGTCGAGGATTCTGTGCCTCCAGGACCAGGGGCCCACCCTC TGCCCAGGGAGTCCTTGCGTCCCATGAGGTCTTCCCGCAAGGCCTCTCAGACCCAGATGTGACGGGGTGTGTGGCCCGAGGAAGCTGGAC AGCGGCAGTGGGCCTGCTGAGGCCTTCTCTTGAGGCCTGTGCTCTGGGGGTCCCTTGCTTAGCCTGTGCTGGACCAGCTGGCCTGGGGTC CCTCTGAAGAGACCTTGGCTGCTCACTGTCCACATGTGAACTTTTTCTAGGTGGCAGGACAAATTGCGCCCATTTAGAGGATGTGGCTGT AACCTGCTGGATGGGACTCCATAGCTCCTTCCCAGGACCCCTCAGCTCCCCGGCACTGCAGTCTGCAGAGTTCTCCTGGAGGCAGGGGCT GCTGCCTTGTTTCACCTTCCATGTCAGGCCAGCCTGTCCCTGAAAGAGAAGATGGCCATGCCCTCCATGTGTAAGAACAATGCCAGGGCC CAGGAGGACCGCCTGCCCTGCCTGGGCCTTGGCTGGGCCTCTGGTTCTGACACTTTCTGCTGGAAGCTGTCAGGCTGGGACAGGCTTTGA >6165_6165_2_ARHGDIA-SQSTM1_ARHGDIA_chr17_79825598_ENST00000582520_SQSTM1_chr5_179250858_ENST00000376929_length(amino acids)=320AA_BP= MVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRP PRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNV EGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ARHGDIA-SQSTM1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 122_224 | 16.333333333333332 | 357.0 | GABRR3 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 122_224 | 16.333333333333332 | 357.0 | GABRR3 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 122_224 | 100.33333333333333 | 441.0 | GABRR3 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 122_224 | 16.333333333333332 | 357.0 | GABRR3 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 347_352 | 16.333333333333332 | 357.0 | KEAP1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 347_352 | 16.333333333333332 | 357.0 | KEAP1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 347_352 | 100.33333333333333 | 441.0 | KEAP1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 347_352 | 16.333333333333332 | 357.0 | KEAP1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 269_440 | 16.333333333333332 | 357.0 | NTRK1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 269_440 | 16.333333333333332 | 357.0 | NTRK1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 269_440 | 100.33333333333333 | 441.0 | NTRK1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 269_440 | 16.333333333333332 | 357.0 | NTRK1 | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 50_80 | 16.333333333333332 | 357.0 | PAWR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 50_80 | 16.333333333333332 | 357.0 | PAWR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 50_80 | 16.333333333333332 | 357.0 | PAWR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 43_107 | 16.333333333333332 | 357.0 | PRKCZ and dimerization | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 43_107 | 16.333333333333332 | 357.0 | PRKCZ and dimerization | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 43_107 | 16.333333333333332 | 357.0 | PRKCZ and dimerization |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000360718 | 0 | 7 | 2_50 | 16.333333333333332 | 357.0 | LCK | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000376929 | 2 | 9 | 2_50 | 16.333333333333332 | 357.0 | LCK | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 2_50 | 100.33333333333333 | 441.0 | LCK | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000402874 | 1 | 8 | 2_50 | 16.333333333333332 | 357.0 | LCK | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 50_80 | 100.33333333333333 | 441.0 | PAWR | |
Tgene | SQSTM1 | chr17:79825598 | chr5:179250858 | ENST00000389805 | 1 | 8 | 43_107 | 100.33333333333333 | 441.0 | PRKCZ and dimerization |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARHGDIA-SQSTM1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ARHGDIA-SQSTM1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ARHGDIA | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | ARHGDIA | C0019693 | HIV Infections | 1 | CTD_human |
Hgene | ARHGDIA | C0022548 | Keloid | 1 | CTD_human |
Hgene | ARHGDIA | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | ARHGDIA | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | ARHGDIA | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | ARHGDIA | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | ARHGDIA | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | ORPHANET |
Hgene | ARHGDIA | C3808874 | ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2 | 1 | GENOMICS_ENGLAND |
Hgene | ARHGDIA | C4505456 | HIV Coinfection | 1 | CTD_human |
Hgene | ARHGDIA | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | C4085252 | PAGET DISEASE OF BONE 3 | 9 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0002736 | Amyotrophic Lateral Sclerosis | 5 | CTD_human;ORPHANET | |
Tgene | C4225326 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3 | 4 | CTD_human;UNIPROT | |
Tgene | C0029463 | Osteosarcoma | 2 | GENOMICS_ENGLAND | |
Tgene | C0221054 | Welander Distal Myopathy | 1 | ORPHANET | |
Tgene | C0242383 | Age related macular degeneration | 1 | CTD_human | |
Tgene | C0393554 | Amyotrophic Lateral Sclerosis With Dementia | 1 | CTD_human | |
Tgene | C0543859 | Amyotrophic Lateral Sclerosis, Guam Form | 1 | CTD_human | |
Tgene | C1853926 | NONAKA MYOPATHY | 1 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C2931290 | Welander distal myopathy, Swedish type | 1 | ORPHANET | |
Tgene | C3888102 | Frontotemporal Dementia With Motor Neuron Disease | 1 | ORPHANET | |
Tgene | C4011788 | Behavioral variant of frontotemporal dementia | 1 | ORPHANET |